ArticleCancers2022

IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab.

Toru Sakatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.